tradmap

TDOC Earnings Teladoc Health, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$85 -$42 $0 2019 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $1B $3B 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$14B -$7B $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$61 -$31 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $330M $661M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$838M -$419M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–24 of 24
Q2 20262026-06-30-0.572026-07-3010-Q
Q1 20262026-03-31-0.362026-04-3010-Q
FY 20252025-12-31-1.142026-02-2610-K
Q3 20252025-09-30-1.002025-10-3010-Q
Q2 20262025-06-30-0.722026-07-3010-Q
Q1 20262025-03-31-0.532026-04-3010-Q
FY 20252024-12-31-5.872026-02-2610-K
Q3 20252024-09-30-5.612025-10-3010-Q
Q2 20252024-06-30-5.442025-07-3010-Q
Q1 20252024-03-31-0.492025-05-0110-Q
FY 20252023-12-31-1.342026-02-2610-K
Q3 20242023-09-30-1.172024-10-3110-Q
Q2 20242023-06-30-0.822024-08-0110-Q
Q1 20242023-03-31-0.422024-04-2610-Q
FY 20242022-12-31-84.602025-02-2710-K
Q3 20232022-09-30-61.092023-10-2710-Q
Q2 20232022-06-30-60.722023-07-2810-Q
Q1 20232022-03-31-41.582023-05-0210-Q
FY 20232021-12-31-2.732024-02-2310-K
Q3 20222021-09-30-2.682022-11-0210-Q
Q2 20222021-06-30-2.162022-08-0310-Q
Q1 20222021-03-31-1.312022-05-0210-Q
FY 20222020-12-31-5.362023-03-0110-K
FY 20212019-12-31-1.382022-02-2810-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.